HERSHEY TRUST COHERSHEY TRUST CO

Institutional investor · Portfolio as of Q3 2023

SEC EDGAR SourceSEC Filings

Top Holdings7 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
HSHSYFBDelisted

HERSHEY COMPANY CLASS B

54.6M$10.9B96.2%
19 qtrssince 2019-Q1
Unchanged
0

HERSHEY CO/THE

2.1M$413.4M3.6%$231.25-19.10%
2 qtrssince 2023-Q2
Unchanged
0

AIRBNB INC-CLASS A

122,353$16.8M0.1%$145.12-5.45%
9 qtrssince 2021-Q3
Increased
44

CRISPR THERAPEUTICS AG

33,758$1.5M0.0%$121.82-55.44%
11 qtrssince 2021-Q1
Unchanged
0

SAMSARA INC

15,791$398,0910.0%$25.210.00%
1 qtr
New
36
EBEBDelisted

EVENTBRITE INC

17,290$170,4790.0%$9.86
1 qtr
New
34

ALECTOR INC

5,143$33,3270.0%$6.480.00%
1 qtr
New
30
$11.4B
AUM
7
Positions
Q3 2023
Filing
Rating · 2.0
Quarterly Portfolio Change
+14%Q4'21$11.9B+10%Q1'22$13.1B-3%Q2'22$12.7B+1%Q3'22$12.8B+5%Q4'22$13.5B-16%Q3'23$11.4B
Activity profile
$ moved · Q3'23
New4%Increased23%Decreased0%Exited73%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.8 years
<1Q14%1-4Q0%1-2Y14%2Y+71%

HERSHEY TRUST CO manages $11.4B across 7 positions as of Q3 2023. Top holdings: HSYFB (96.2%), HSY (3.6%), ABNB (0.1%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q3 2023 Summary

Added 3 new positions, exited 3, increased 1. Top move: ABNB (INCREASED, conviction 44). Portfolio: $11.4B across 7 positions.

Top holdings by portfolio weight

Total AUM$11B
HSYFB96.19%
HSY3.64%
ABNB0.15%
CRSP0.01%
IOT0.00%
EB0.00%
ALEC0.00%
MEITUAN DIAN0.00%
RPTX0.00%
GTM0.00%

Portfolio allocation by GICS sector

Sectors6
Unknown96.19%
Consumer Defensive3.64%
Consumer Cyclical0.15%
Healthcare0.01%
Technology0.00%
Communication Services0.00%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction39
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used